The Global Oxygen Therapy Equipment Market is expected to witness a growth rate of 6-7% in the next five years. Increasing ...

Needham analysts upped Inogen, Inc. (NASDAQ:INGN)’s stock from “Hold” to “Buy”, offering a price objective of $12.00. The ...

Given the company’s current exemptions, Inogen does not anticipate material impact on its operating plan or financial profile ...

Portable oxygen concentrators are small, mobile devices that condense the environment’s oxygen. They allow people to inhale more oxygen than usual. Medicare Part B covers portable oxygen ...

Discover Inogen's Q1 2025 earnings insights, featuring 5.5% revenue growth, B2B focus, UL Medical collaboration, and strategies for DTC stabilization ...

As a reminder, UL will distribute Inogen portable oxygen concentrators under the Inogen brand in China, accelerating our entry into the attractive Chinese respiratory market. We will be ...

Inogen reported total revenue of $82.3 million for the first quarter of 2025, a 5.5% increase compared to the same period ...

(AP) — Inogen Inc. (INGN ... Investment Research was for a loss of 52 cents per share. The produces oxygen concentrators for patients suffering from chronic respiratory conditions posted ...

Researchers at the University of Liège (BE) have designed a high-performance, open-access continuous flow process to safely produce key antibacterial drugs from bio-based furfural. The results of ...